Hemat Patho Flashcards
BM exam
- BM aspirate
- BM Bx ( more representative , more painful)
indications of BM Bx
- dry tap
- assess bm cellularity (100 - age)
- assess mets in marrow
- lymphoma staging ( marrow + stage 4)
- MPN
- Storage dis (gaucher)
dry tap
- aplastic anemia <25% HSC cells BM
- myelofibrosis
- hairy cell leukemia (honey comb, fried egg)
oncohemat classfn
MPN MP/MDS MDS AL Lymphomas
Acute leukemia Dx
> 20% BLASTS (2.5-3 times RBC size)
either PS or BM
mc AUER rods
mod amt cytoplasm
cyto granules +
multiple nuclei
Myeloblasts
AML
MPO +
SBB +
AML myeloblasts
NSE +
monoblasts
TRAP +
hairy cell leukemia
scant rim cyto
absent granules
single nucleus
BLOCK + PAS
ALL
lymphoblasts
immunophenotyping by?
flow cytometry
streamlining cells in single linear flow
mc blue laser 488nm
- side scatter
- fwd scatter
- side scatter = granules NEUTROPHILS
- fwd scatter = size BLASTS
Characteristic of BM sample
mekakaryocyte
CD 19
CD 3
CD 34
CD 19 B CELL
CD 3 T CELL
CD 34 BLAST
B cell markers 19 20 10 22, 79a
19 PAN B
20 MATURE B
10 IMMATURE B
22, 79a OTHERS
T cell markers
3
4,8,2,5,7
thymus schooling — cyto shows APC
Pan - 3
myeloid markers
- specific
- myeloid ass
- specific MPO
- myeloid ass CD 13,33,117
NK cell
16
56
monocytes
4
64
stem cells
34
99
TdT (terminal deoxytransferase)
Pan LEUCOCYTE
45
LCA
AL
AML
ALL (B&T)
MPAL (mixed pheno AL)
best marker to diff hematolymphoid ca vs mets
45
MPAL types
BALL + AML mc
TALL + AML
BALL + TALL
BALL + TALL + AML all 3 = triphenotypic RAREST
MPN
CML PV ET PMF CEL (eosinophilic) CNL (neutrophilic)
high TLC
shift to left ( immature myeloid in PS)
ass with BASOPHILIA
normal myeloid maturation
CML
CML vs AL
CML - blasts + PM + M + Band
AL = only 90% BLASTS
TLC > 1 lakh
blasts +
LAP score LOW (0-4)
CML
TLC < 1 lac
absent blasts
HIGH LAP (400)
Leukemoid reacn
normal LAP
80-130
low LAP causes
CML
PNH
HIGH LAP causes
leukamoid reacn
HODGKINS
PV (HIGHEST overall)
CML in blast crisis
stages of CML
- chronic (blasts <10%)
- accelerated (10-19%)
- blastic crisis
10-19% blasts
platelet <1lac or >10lac
basophilia >20%
1/3 Dx accelerated CML
> 20% blasts
presence of extramed disease
CML blast crisis
mc phase where CML detected
chronic phase
Dx hallmark of CML
fusiion trascript BCR-ABL by PCR (higher specificity and sens than conventional karyo/cytogenetics) for Ph Ch
BCR
ABL
22
9
bcr-abl Px
p190
p210
p230
p190 POOR BALL
p210 GOOD :) mc CML, AML
p230
hypercellular marrow + predom myeloid lineage
BM in CML
M:E HIGH
normal M:E = 3-15:1
dis of firsts?
CML
- 1st to fusion transcript
- 1st targetted gene Rx
- 1st recurrent cytogenetic abN detected
criteria for complete hemat remission in CML
- TLC normal
- NO immature cell in PS
- baso <5%
- platelet Normal counts
- absent extramedullary dis
most sig Prognostic marker in CML
MMR
major mol remission = real time PCR/q PCR
high Hb reactive causes of erythrocytosis ruled out low S. EPO clonal mutation + BM hypercellular PANMYELOSIS
PV
reactive causes of erythrocytosis
HIGH EPO smoking high alt copd athelete
PV mutation mc
also in ET and PMF
JAK 2 V 617 F
valine to Phenylalanine
PC > 4.5 lac
reactive causes of thrombocytosis r/o
clonal mutations
ET
reactive causes of thrombocytosis
IDA
infections
ET Mutation
- JAK 2 same
- MPL mutation
fibrosis of marrow NOT A PREREQUISITE
tear drop cell
PMF
stages of PMF
- cellular phase : hyper cellular and dysplastic megakaryocytes
- fibrotic phase
IOC MPN
BM Biopsy
not cytogene/PCR/etc
all are useful in MPN except
flow cytometry
pt with CHLOROMAS next best step
PS
- AML
_ CML
MPN/MDS types
- atypical CML
- CMML
- JMML (HbF high)
high TLC + shift to left bcrabl -ve elderly blasts not raised no basophilia
atypical CML
monocytes raised in PS > 1000
bcr abl -ve
HbF +
CMML or JMML
ps pancytopenia
- hypocellular BM (aplastic anemia <25%)
- hyper cellular BM
mc adults
MDS
hypocellular BM (aplastic anemia <25%)
MDS
PNH
megaloblastic anemia
infections
auoimmune
hypercellular in MDS
PNH
M/C
PNH usually progresses to?
aplastic anemia
lap score when AA progresses to PNH?
decreases
all are preleukemic except
PCH!
- pnh
- mds
- aa
AA can progress to all except
- PRCA
- pnh
- mds
- aml
AA can become PRCA?
NO
MDS types
RCUD RCMD RARS RAEB MDS + isolated 5q del
refractory cytopenias
MDS
do not respond to usual Rx
abN in 1 lineage RBC
- ref anemia
- ref leucopenia
- ref thrombocytopenia
> 10% of 1 lineage is AbN
RCUD
ref cytopenia f unilineage dysplasia
> 1 lineage affected
> 10% of each cell line abN
RCMD
ref cytopenia of multilineage dysplasia
erythroid
stains + PRUSSIAN BLUE (PEARLS stain)
>15% erythroid cells RINGED SIDEROBLASTS
RARS
ref anemia with ringed sideroblasts
PS vs BM
<5% 5-9%
5-19% 10-19%
RAEB 1
RAEB 2
ref anemia with excess blasts
mc cytogenetic abN in MDS
good px
PS - thrombocytosis
MDS with isolated 5q del
mc cytogenetic abN MDS overall
5q del
mc cytogenetic abN MDS adults
5q del
mc cytogenetic abN MDS children
monosomy 17
POOR PROGNOSIS
ALL
B
T
BALL mc 85-90%
TALL 10-15%
BALL good Px
1-10y
t(12,21)
HYPER diploidy
BALL poor Px
high TLC high blasts % LN + HSM <1y or >10y males testis+ CNS + t(9;22) p190 bcr abl infantile leukemia hypodiploidy
infantile leukemia
mc t(4;11)
ALL FAB classfn
L1 same size of blasts POORER PX
L2 varying sizes
L3 BURKITTS
Most sig Px marker in ALL
minimal residual dis
Assess chemoRx response
AML types
M0-7
mc AML
lc AML
mc - M2
lc - M7
M7
acute megakaryocytic
CD 41
61
MPO -ve AML
M0, 6, 7
M6
acute ERYTHROLEUKEMIC
CD 36, 71
glycophorin A +ve
best Px AML
M3
M3
acute promyelocytic
mc t(15;17)
PML RARA
CVS # - NBTE
PML RARA Rx
ATRA
all trans retinoic acid
mc COD - DIC
DIC mc in which AML
M3
M4
acute myelomonocytic
M5
acute mnocytic
NSE +ve
CD 14
16
monocytic leukemias
M4&5
mc leukemia ass with DOWNS
ALL - M7
mc AML ass with
- chloromas
- BM fibrosis
- leukemia cutis
- chloromas 2
- BM fibrosis 7
- leukemia cutis 5
good Px in AML
t(15;17) PML RARA M3
t(8;21) AML ETO/RUNX1- RUNXITI M2
inv 16 M4eo
16% of blasts in BM which are
- AML ETO+ve
- AML ETO -ve
- AML ETO+ve M2
- AML ETO -ve MDS RAEB2
hodkins mc REAL WHO classfn
- classical
- lymphocyte predom
mixed cellularity mc INDIA
nodular sclerosis mc WEST mc females
lymphocyte rich
L depleted WORST Px
classical hodgkins
best Px hodgkins
lymphocyte predominant hodgins
RS reed steenberg cells in reactive background
OWL EYE ap
PS of hodgkins
CD 15
30
except in lymphocyte predom?
Hodgkins
lymphocyte predom = 15- , 30- , 20+
variant of RS cells
- popcorn
- lacunar
L&H cell
popcorn cell
lymphocyte and histiocytic cell
LYPMPHO PREDOM
lacunar cell
Nodular sclerosis
HL shows bomodal age
- young
- >45y
Ann arbor
HL
- single LN
- > 1LN same side of diaph
- > 1LN on opp side of diaph
- BM +
mc NHL
B NHL MATURE
- SLL/CLL
- Follicular lymphoma
- mantle cell lymphoma
- marginal cell lymphoma
mature B NHL
CD 19+ve
5+ , 23+ , 200+
19+
small lymphocytic lymphoma
chronic lymphocytic lymphoma
SLL /CLL
5- , 10+
mc t(14;18)
bcl2+
follicular lymphoma
5+, 10-, 23-
mc t(11,14) bcl 1+
cyclin D1 +ve
mantle cell lymphoma
cyclin D1 -ve Mantle
SOX 11 +ve
5-, 10-
marginal cell lymphoma
mc NS
- adults
- > 40y
- adults FSGS
- >40y MGN (west - FSGS only)
mc NHL in INDIA
DLBCL
bcl 6 +ve
(west - follicular)
mc HL ass with EBV
mixed cellularity
mc EBV -ve HL
lymphocyte predom
mc HL with HIV
lypmphocyte depleted HL increased incidence BUT
mc - MIXED CELLULARITY
high TLC with mature ap lymphocytes
smudge cells mc
characteristic RBC (SPHAEROCYTES - warm AIHA)
SLL/CLL
Px markers of SLL/CLL
GOOD
- IgVH hypermutation (PCR)
surrogate: ZAP 70 protein expression - ZAP 70 +ve BAD
- mc cytogenetics - NORMAL
mc cyto abN del 13q GOOD - BAD Px if Del in 11 and 17
burkitt types
- african
- non endemic or sporadia
- hiv
80-90% ebv +
mc mandible
mc t(8;14)
others (2;8) and (8;22)
african or endemic burkitt
20-30% ebv
ileocecal region
c myc protoonc mutation
non endemic burkitt
30-40% ebv
LN +
n myc ass with neuroblastoma
HIV ass burkitt
classical triad
19+
34-
sIgM +
mature B cell neoplasm
starry sky LN
stars - macrophages
sky - burkitt cells
large cells with blue cyto
baso cyto
cyto vacuoles
PS and BMA in burkitts
- inc PLASMA with any 1 of CRAB
- plasma >60% in absence of CRAB
- mc IgG IL 6 overexpression
- M band on electrophoresis
- large cell with eccentric nucleus
- PS: roloulaux STACK OF COINS, >20% plasma cells
MM
normal MCV
80-100
immature RBC in PS
indicator of marrow erythropoesis
Reticulocyts
Normal - 0.5 - 2.5%
supravital stain
mc methylene blue
brilliant cresyl blue
retic
CRC
Retic count x Hb of pt / normal Hb
low retic count
- aplastic anemia
- nutritional anemia
- CKD
- ACD
- Myelofibrosis
high retic
- hemolytic anemia
- nutritional anemia on Rx PEAKS ON DAY 7
microcytic hypochromic
- IDA mc
- thal
sideroblastic - ACD rarely
nromocytic normochromic
HIGH retic - hemolytic anemia LOW retic - 1. aplastic 2. ACD 3. CKD 4. myelofibrosis
macrocytic
megaloblastic 9+12
non megalo - liver dis
mc cause of anemia in hosp pt
ACD
mc anemia in ACD
normocytic normochromic
nucleo cyto async
megalo
nucleus - immature
cyto - mature
MYELOCYTES & METAMYELOCYTES
orthochromatic Hb
intermediate normoblast
1st feature on PS in megalo
HS neutrophil
- > 5lobes in 1
- 5 lobes in 5%
anemia classfn on etiology
- blood loss
- hemolysis
- dec prodn
hemolytic anemia causes
- HS mc memb# AD
- G6PD mc enz# XR
- Hb pathies
Hb pathies
- sickle cell AR
- thal AR
- PNH acquired
- autoimmune hemolytic acquired
dec prodn of rbc
nutrition ACD CKD MF AA
AD
mc rbc memb# ANKYRIN
HS
transmemb anion transporter (BAND3) protein 4.2 (PALLIDIN) ankyrin beta spectrin alpha spectrin
outer
to
inner
HS most severe defect
ALPHA SPECTRIN
reduced deformability by sphaerocyte
splenic entrapment
HEMOLYSIS extravas
HS
RBC + vary conc NS
osmotic fragility testing
- SHIFT TO RIGHT in normal signmoid curve
osmotic fragility testing
- SHIFT TO RIGHT
HS
AIHA
osmotic fragility testing
- SHIFT TO LEFT
SICKLE CELL
IDA
THAL
oxidative damage to globin chain chain ppts in RBC HEINZ bodies formed BITE cells high retic count
G6PD
beingn self limiting
site of hemolysis in g6pd
intra and extra vas
intra and extra vas
g6pd sickle cell (spleen) autoimmune COLD Ab (liver)
mc clinically sig variant of gdpd def
mediterranean type
most severe
low t1/2
g6pd test
methHb reduction test
point mutation in 6th codon of beta chain
Glu acid —> Valine
polymer on deO2
Irreversibly sickled later
sickle cell anemia
vaso occlusive crisis
splenic changes +
inc risk of infections
aplastic crisis
sickle cell anemia
dactilitis of bones of hand and feet stroke retinopathy conj vessels COMMA SIGN priapism
vaso occlusive crisis
splenic changes + sickle cell
1st change - spleen enlarged
multiple ifarcts
autosplenectomy
H influenza
Strep pneumonia
mc OM in sicle cell - salmonella
inc risk of infections
SPLENECTOMY INDICATED in
HS?
Sickle cell?
HS YES!
Sickle cell NOOO
aplastic crisis in sickle cell
Parvovirus B 19
erythroid precursor in BM #
screening test of choice in sickle cell
Hb Electrophoresis
IOC for Hb pathies
HPLC
- quantitative test
normal Hb
A a2b2: 88-95%
A2 a2d2: 2-3.5%
F a2g2: <1%
main indication for HbElecrophoresis
screenignof woman by end of 1st trimester for thal minor
thal minor HbElectro
HbA2 >3.5% (but <8%)
run sample on agar
Hb -ve charge
cathode - Sample - A2 - S - F - A - anode
HbElecrophoresis
Hb migrating to A 2 region
A2
C
E mc
Hb migrating to S region
S
D punjab
G
what is motility of S compared to Hb A?
reduced
- size dep
- charge dep
- NOT CONC DEPENDENT!
dec alpha chains
GENE DELETIONS
alpha thal
de beta chains
POINT MUTATION
beta thal
A decreased, F increased
HbH b4
Hb barts g4
physio useless
AR
Heterozygous MINOR
homozygoous MAJOR
beta thal
2 chains
4 chains - del 1 chain 2 3 4
1 chain - asymp carrier
2 - thal MINOR
3 - HbH
4 - Hydrops fetalis
Mentzer index
MCV/
RBC count
13
hypochromia f/b microcytosis
thal minor
microcytosis f/b hypochromia
IDA
RDW normal
11.5-14.5%
RDW increases
IDA
normal in thal minor!
CD 55
DAF decay accelerating factor
stops action of C3 convertase
CD 59
MIRL memb inhibitor of reactive lysis
stops MAC c5b-9
PNH
def of CD 55 and «< 59 (hemolysis)
acq mutation in PIGA gene on X Ch def of Gp1 linked anchor protein
acq clonal stem cell
NOT AUTOIMMUNE
coombs -ve
mc mortality in pnh
thrombosis
- unusual sites Portal v, hepativ v , cerebral vein BUDD CHIARI
tests for pnh
- hams (acid serum lysis)
- sucrose lysis ( more sens)
- mc GEL CARD (red ring NOZRMAL )
- flow cytometry
- FLAER fluroscent pro serolysin test (most specific for pnh f/b flow cytometry
IgG AIHA
warm
may or may not fix complement
37 deg
EXTRAVAS HEMO (SPLEEN)
IgM AIHA
cold fixes complement 4 deg BOTH EXTRA mc and @liver AND INTRA mycoplasma pneumonia +
ass with CLL
shift to right
Ag: BAND 3
warm AIHA
tests for AIHA
coombs
- direct (Ab on RBC surface)
- indirect
pt blood + Anti human globin = agglutintn
direct coombs
Ab in serum of pt + Sheep rbc + AHG = Agglutn
indirect coombs
PS with sphaerocyte next inv
coombs
IgG (exception to rule)
Donath landsteiner Ab
p blod gp Ag
PCH
burr cells
ECHINOCYTES
spicules on rbc - eq size and eq spaced
mc artifact
spur cells/ acanthocytes
spicules uneq lenth and spaced
LIVER DIS ABETALIPO
bite cells
g6pd def
myelofibrosis
tear drop
howell jolly
cabot ring
megaloblastic anemia
post splenectomy
thal
pappenheimer bodies
sideroblastic anemia
sphaerocyites
HS
AIHA
most alarming hemolysis
schistocytes MAHA DIC HUS - SHIGA TOXIN 0157:H7 TTP - ADAM TS 1 def HELLP march Hburia def of complement factors BHI prosthetic heart valves
manual Platelet count
false low due to clumping
falciparum RBC
malairae
vivax
banana
rbc left
complete rbc destroyed
severe anisopoikilo
microhpochromic
target cells
no inc rbc
thal MAJOR
basophilic stippling
Pb poisoning
thal
megalo
stages of IDA
- dec stores
- Fe def erythropoeisis
- MCHC
Stage 1 IDA
BM iron DEC S ferritin DEC (most sens) TIBC INC S Fe NORMAL %transferrin sat NORMAL PS NCNC
Stage 2 IDA
S Fe DEC
%transferrin sat DEC
PS NCNC
Stage 3 IDA
PS MCHC
thrombocytosis
secondary to IDA
megalo
most characteristic - pancytopenia
low retic count
after rx of megalo
- BM changes become Normal in 24h
- PC normal in 1 wk
- last to disappear are HS neutrophils 2 wks
mc dis causing ACD
- TB
- typhoid
- hiv
- autoimmune
- CTD
dis NOT ASS with ACD
- CKD anemia
- anemia in CLD
- worm infestation
- any cause of chronic blood loss
ACD patho
- inc HEPCIDIN block
- cytokines and chemokines suppressing erythropoesis
- reduced rbc survival 60-80 days